Vignola Mark J. 4
4 · Terns Pharmaceuticals, Inc. · Filed Sep 30, 2021
Insider Transaction Report
Form 4
Vignola Mark J.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-09-28+120,000→ 120,000 totalExercise: $10.72Exp: 2031-09-28→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from September 28, 2021 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.